Welcome to Brecise
BRECISE (Biomarker Research and Evaluation for Clinical Implementation and Supporting Systems Enhancement) is a European-funded initiative dedicated to integrating biomarker
research into clinical practice. Our mission is to advance personalized medicine by bringing together researchers, healthcare professionals, and industry leaders to improve patient outcomes through innovative diagnostic solutions.
Unlocking the Future of Personalized Medicine
Precision medicine is transforming healthcare—delivering treatments tailored to each patient’s unique biology. At BRECISE, we accelerate the clinical validation of biomarkers, ensuring earlier diagnoses, more effective therapies, and better patient outcomes. By integrating cutting-edge AI, next-generation sequencing, and biomarker-driven strategies, we are shaping a future where medicine is truly personalized.
Biomarker research for a healthier future
Imagine a future where diseases are detected earlier, treatments are precisely tailored, and every patient gets the right care at the right time.
At BRECISE, we’re making that future a reality. As a European-funded initiative, BRECISE is at the forefront of integrating biomarker research into clinical practice. Funded under the Horizon Europe IHI JU program, BRECISE is an ambitious, international research initiative that aims to improve patient care by ensuring biomarker-driven diagnostics and therapies are scientifically validated and seamlessly adopted into clinical workflows.
By uniting top scientists, healthcare professionals, and industry leaders, we’re driving the next generation of precision medicine—where innovation meets real-world impact.
What we do
BRECISE advances biomarker research to improve diagnosis and treatment. We standardize testing, streamline regulatory approvals and integrate biomarkers into clinical practice. By leveraging AI and collaborating with healthcare leaders, we ensure biomarker-driven precision medicine becomes the new standard in patient care.
Who we are
BRECISE is a consortium of 25 partners, including top academic institutions, healthcare organizations, industry leaders, and regulatory bodies, all working towards the future of precision medicine.
Why Biomarkers matter
Biomarkers are biological indicators that enable early disease detection, accurate diagnosis, and personalized treatment. In fields like oncology, neurology, and cardiovascular medicine, they help guide targeted therapies, reducing ineffective treatments and improving patient outcomes. BRECISE accelerates biomarker adoption to enhance healthcare efficiency, lower costs, and improve treatment effectiveness worldwide.
EVENTS
Project Plenary Meeting, Madrid (March 2025.)
The BRECISE project is set to hold its first face-to-face kick-off meeting in Madrid on March 20–21, 2025. This event will bring together project partners
PUBLICATIONS
BRECISE Overview
The project aims to accelerate the clinical validation and implementatioon of Next-Generation Sequencing….
Join us.
Our mission for a better future.
At BRECISE, we are committed to transforming healthcare through innovation. By advancing biomarker research and integrating precision medicine into clinical practice, we aim to improve diagnoses, optimize treatments, and enhance patient outcomes. Our mission is to create a future where every individual receives the right care at the right time—ensuring better health, greater efficiency, and a stronger healthcare system for all.